Search For "balram bhargava"
Deaths have been considerably reduced due to COVID-19 vaccination: ICMR
Updated : 4 years, 4 months ago IST
New Delhi [India], January 20 (ANI): Indian Council of Medical Research (ICMR) head Dr Balram Bhargava, in a health briefing, on Thursday asserted that deaths have been considerably reduced due to COVID-19 vaccinations in this third surge of the coronavirus infection.
Read More
India was able to provide COVID-19 vaccines to over 100 countries with phi
Updated : 4 years, 4 months ago IST
New Delhi [India], January 16 (ANI): As India marks one year of the COVID-19 vaccination drive on Sunday, Dr Balram Bhargava, DG ICMR said that the country was able to provide vaccines to over 100 countries in line with our philosophy of 'Vasudhaiva Kutumbakam'.
Read More
Molnupiravir does not come under National Treatment Task Force for COVID-1
Updated : 4 years, 4 months ago IST
New Delhi [India], January 12 (ANI): Antiviral drug Molnupiravir is not included in the National treatment task force for COVID-19, said Director General, Indian Council of Medical Research (ICMR) Balram Bhargava on Wednesday.
Read More
ECI meets AIIMS chief, ICMR DG to review COVID-19 situation ahead of Assem
Updated : 4 years, 4 months ago IST
New Delhi [India], January 6 (ANI): Ahead of Assembly polls to five states, the meeting of the Election Commission of India (ECI) and top officials of the health ministry on Thursday to review the COVID-19 situation was attended by AIIMS Director Dr. Randeep Guleria and ICMR Director General
Read More
COVID-19: Oral anti-viral drug Molnupiravir is not included in national ta
Updated : 4 years, 4 months ago IST
New Delhi [India], January 5 (ANI): Indian Council of Medical Research (ICMR) head Dr. Balram Bhargava on Wednesday stated that the oral anti-viral drug Molnupiravir capsules are not included in the national task force treatment for COVID-19 as it has side effects.
Read More
DCGI approves India-made RT-PCR kit to detect Omicron: Centre
Updated : 4 years, 4 months ago IST
New Delhi [India], January 5 (ANI): An RT-PCR test kit for detecting new coronavirus variant Omicron has been developed in India in partnership with Tata MD and the Indian Council of Medical Research (ICMR), said Dr Balram Bhargava, Director General of ICMR on Wednesday.
Read More
Omicron is predominant circulating strain in India: Centre
Updated : 4 years, 4 months ago IST
New Delhi [India], January 5 (ANI): The new coronavirus variant, Omicron, is the predominant circulating strain in India, Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava said on Wednesday.
Read More
Durability of immunity post-COVID-19 infection persists for 9 months: DG I
Updated : 4 years, 4 months ago IST
New Delhi [India], December 30 (ANI): The durability of immunity after the COVID-19 infection persists for at least 9 months as per the evidence-based studies from different countries globally, said Dr. Balram Bhargava, Director General, Indian Council of Medical Research (ICMR) on Thursd
Read More
COVID vaccines are disease-modifying, don't prevent infection: ICMR
Updated : 4 years, 4 months ago IST
New Delhi [India], December 30 (ANI): All COVID vaccines do not prevent infection and are primarily disease-modifying, said Dr Balram Bhargava, Director General, Indian Council of Medical Research (ICMR) on Thursday.
Read More
COVID-19: Mask usage declining; WHO warning against it, says NITI Aayog's
Updated : 4 years, 5 months ago IST
New Delhi [India], December 10 (ANI): Dr VK Paul, Member-Health of NITI Aayog, on Friday expressed concern over the decline in the use of face masks in the country and said that the World Health Organisation (WHO) has warned against it as the global scene of the Omicron variant of COVID-1
Read More
Establish regulatory frameworks pertaining to control of air pollution at
Updated : 4 years, 6 months ago IST
New Delhi [India], November 15 (ANI): Indian Council of Medical Research (ICMR), National Institute for Implementation Research on Non-Communicable Diseases (NIIRNCD) along with Lancet published a report on Monday highlighting the urgent need to establish regulatory frameworks pertaining to
Read More
WHO EUL approval opens up Covaxin for worldwide use: ICMR DG
Updated : 4 years, 6 months ago IST
New Delhi [India], November 4 (ANI): Following the World Health Organization's (WHO) Emergency Use Listing (EUL) for Bharat Biotech's COVID-19 vaccine, Covaxin, Indian Council of Medical Research (ICMR) Director General Balram Bhargava on Wednesday said the approval has now opened up the ind
Read More